| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |